Soy Protein Effects on Serum Lipoproteins: A Quality Assessment and Meta-Analysis of Randomized, Controlled Studies

Journal of the American College of Nutrition

Volumn 30, Issue 2, 2011, Pages 79-91

  Anderson, James W ^a   Bush, Heather M ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA BASE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; PARALLEL DESIGN; PROTEIN INTAKE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SOYBEAN PROTEINS; TRIGLYCERIDES; VEGETABLE PROTEINS;

EID: 79960401023     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2011.10719947     Document Type: Article

References (73)

1. Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of effects of soy protein intake on serum lipids in humans. N Engl J Med 333:276-282, 1995.
2. Sirtori CR, Eberini I, Arnoldi A: Hypocholesterolaemic effects of soya proteins: results of recent studies are predictable from the Anderson meta-analysis data. Br J Nutr 97:816-822, 2007.
3. Department of Health and Human Services, Food and Drug Administration: Food labeling: health claims; soy protein and coronary heart disease. Fed Reg 64:57700-57733, 1999.
4. Sacks FM, Lichtenstein A, Van HL, Harris W, Kris-Etherton P, Winston M: Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113:1034-1044, 2006.
5. Balk E, Chung M, Chew P, Ip S, Raman G, Kupelnick B, Tatsioni A, Sun Y, Wolk B, DeVine D, Lau J: ''Effect of Soy on Health Outcomes: Summary, Evidence Report/Technology Assessment'' (Number 126, AHRQ Publication Number 05-E024-1. 8-1-2005). Rockville, MD: Agency for Healthcare Research and Quality, 2005.
6. Harland JI, Haffner TA: Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis 200:13-27, 2008.
7. Yeung J, Yu TF: Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Nutr J 2:15, 2003.
8. Zhan S, Ho SC: Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397-408, 2005.
9. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A: Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 31:140-149, 2002.
10. Lathyris DN, Trikalinos TA, Ioannidis JP: Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials. Int J Epidemiol 36:422-430, 2007.
11. Anderson JW: Weight loss and lipid changes with low-energy diets. Agro Food 18:1-2, 2007.
12. Dewell A, Hollenbeck PL, Hollenbeck CB: Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab 91:772-780, 2006.
13. Anderson JW, Story L, Sieling B, Chen WJL: Hypocholesterolemic effects of high-fibre diets rich in water-soluble plant fibres. J Canad Dietet Assoc 45:140-149, 1984.
14. Anderson JW, Liu C, Kryscio RJ: Blood pressure response to Transcendental Meditation: a meta-analysis. Am J Hypertens 21:310-316, 2008.
15. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P: Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148:295-309, 2008.
16. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12, 1996.
17. Pickering TG, Shimbo D, Haas D: Ambulatory blood-pressure monitoring. N Engl J Med 354:2368-2374, 2006.
18. Appel LJ, Moore TJ, Obarzanek E, Vollmer, WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336:1117-1124, 1997.
19. Higgins JPT, Green S: ''Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration.'' New York: John Wiley & Sons, 2008.
20. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F: ''Methods for the Meta-Analysis in Medical Research.'' New York: John Wiley & Sons, 2000.
21. Allen JK, Becker DM, Kwiterovich PO, Lindenstruth KA, Curtis C: Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women. Menopause 14:106-114, 2007.
22. Baum JA, Teng H, Erdman JW, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NK, Potter SM: Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68:545-551, 1998.
23. Chen ST, Ferng SH, Yang CS, Peng SJ, Lee HR, Chen JR: Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients. Am J Kidney Dis 46:1099-1106, 2005.
24. Chen ST, Chen JR, Yang CS, Peng SJ, Ferng SH: Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis. Br J Nutr 95:366-371, 2006.
25. Crouse JR III, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL: A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159:2070-2076, 1999.
26. Dalais FS, Ebeling PR, Kotsopoulos D, McGrath BP, Teede HJ: The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) 58:704-709, 2003.
27. Dent SB, Peterson CT, Brace LD, Swain JH, Reddy MB, Hanson KB, Robinson JG, Alekel DL: Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. J Nutr 131:2280-2287, 2001.
28. Gardner CD, Newell KA, Cherin R, Haskell WL: The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 73:728-735, 2001.
29. Hoie L, Morgenstern ECA, Gruenwald J, Graubaum H-J, Busch R, Luder W, Zunft H-J: A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects. Eur J Nutr 44:65-71, 2005.
30. Hoie LH, Graubaum HJ, Harde A, Gruenwald J, Wernecke KD: Lipid-lowering effect of 2 dosages of a soy protein supplement in hypercholesterolemia. Adv Ther 22:175-186, 2005.
31. Hoie LH, Guldstrand M, Sjoholm A, Graubaum HJ, Gruenwald J, Zunft HJ, Lueder W: Cholesterol-lowering effects of a new isolated soy protein with high levels of nondenaturated protein in hypercholesterolemic patients. Adv Ther 24:439-447, 2007.
32. Puska P, Korpelainen V, Hoie LH, Skovlund E, Lahti T, Smerud KT: Soy in hypercholesterolaemia: a double-blind, placebocontrolled trial. Eur J Clin Nutr 56:352-357, 2002.
33. Puska P, Korpelainen V, Hoie LH, Skovlund E, Smerud KT: Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholesterolaemia: a double-blind, placebo-controlled trial of a yoghurt formulation. Br J Nutr 91:393-401, 2004.
34. Santo AS, Cunningham AM, Alhassan S, Browne RW, Burton H, Leddy JJ, Grandjean PW, Horvath SM, Horvath PJ: NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile. Appl Physiol Nutr Metab 33:489-500, 2008.
35. Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N, Shimizu H: Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev Med 31:308-314, 2000.
36. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP: Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin EndocrinolMetab 86:3053-3060, 2001.
37. Teede HJ, Dalais FS, Kotsopoulos D, McGrath BP, Malan E, Gan TE, Peverill RE: Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women. J Clin Endocrinol Metab 90:1936-1941, 2005.
38. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW Jr, Hasler CM: Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 71:1077-1084, 2000.
39. Tonstad S, Smerud K, Hoie L: A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76:78-84, 2002.
40. Vigna GB, Pansini F, Bonaccorsi G, Albertazzi P, Donega P, Zanotti L, DeAloysio D, Mollica G, Fellin R: Plasma lipoproteins in soy-treated postmenopausal women: a doubleblind, placebo-controlled trial. Nutr Metab Cardiovasc Dis 10:315-322, 2000.
41. Ashton E, Ball M: Effects of soy as tofu vs meat on lipoprotein concentrations. Eur J Clin Nutr 54:14-19, 2000.
42. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, Willett WC: Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 85:735-741, 2007.
43. Blum A, Lang N, Peleg A, Vigder F, Israeli P, Gumanovsky M, Lupovitz S, Elgazi A, Ben-Ami M: Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J 145:E7, 2003.
44. Bricarello LP, Kasinski N, Bertolami MC, Faludi A, Pinto LA, Relvas WG, Izar MC, Ihara SS, Tufik S, Fonseca FA: Comparison between the effects of soy milk and non-fat cow milk on lipid profile and lipid peroxidation in patients with primary hypercholesterolemia. Nutrition 20:200-204, 2004.
45. Gardner CD, Messina M, Kiazand A, Morris JL, Franke AA: Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic adults: a randomized trial. J Am Coll Nutr 26:669-677, 2007.
46. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS: Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr 134:3277-3283, 2004.
47. Hermansen K, Soondergaard M, Hoie L, Carstensen M, Brock B: Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24:228-233, 2001.
48. Higashi K, Abata S, Iwamoto N, Ogura M, Yamashita T, Ishikawa O, Ohslzu F, Nakamura H: Effects of soy protein on levels of remnant-like particles cholesterol and vitamin E in healthy men. J Nutr Sci Vitaminol (Tokyo) 47:283-288, 2001.
49. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL: Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25:1709-1714, 2002.
50. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG: Effects of high-and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76:365-372, 2002.
51. Lichtenstein AH, Jalbert SM, Adlercreutz H, Goldin BR, Rasmussen H, Schaefer EJ, Ausman LM: Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol 22:1852-1858, 2002.
52. Matthan NR, Jalbert SM, Ausman LM, Kuvin JT, Karas RH, Lichtenstein AH: Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr 85:960-966, 2007.
53. McVeigh BL, Dillingham BL, Lampe JW, Duncan AM: Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr 83:244-251, 2006.
54. Meyer BJ, Larkin TA, Owen AJ, Astheimer LB, Tapsell LC, Howe PR: Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab 48:67-78, 2004.
55. Onning G, Akesson B, Oste R, Lundquist I: Effects of consumption of oat milk, soya milk, or cow's milk on plasma lipids and antioxidative capacity in healthy subjects. Ann Nutr Metab 42:211-220, 1998.
56. Sirtori CR, Pazzucconi F, Colombo L, Battistin P, Bondioli A, Descheemaeker K: Double-blind study of the addition of highprotein soya milk v. cows' milk to the diet of patients with severe hypercholesterolaemia and resistance to or intolerance of statins. Br J Nutr 82:91-96, 1999.
57. Sirtori CR, Bosisio R, Pazzucconi F, Bondioli A, Gatti E, Lovati MR, Murphy P: Soy milk with a high glycitein content does not reduce low-density lipoprotein cholesterolemia in type II hypercholesterolemic patients. Ann Nutr Metab 46:88-92, 2002.
58. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ: Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78:123-130, 2003.
59. Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP, Erdman JW Jr: Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134:1874-1880, 2004.
60. Thorp AA, Howe PR, Mori TA, Coates AM, Buckley JD, Hodgson J, Mansour J, Meyer BJ: Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers. Am J Clin Nutr 88:298-304, 2008.
61. Washburn S, Burke GL, Morgan T, Anthony M: Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6:7-13, 1999.
62. Welty FK, Lee KS, Lew NS, Zhou JR: Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 167:1060-1067, 2007.
63. West SG, Hilpert KF, Juturu V, Bordi PL, Lampe JW, Mousa SA, Kris-Etherton PM: Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy. J Womens Health (Larchmt) 14:253-262, 2005.
64. Sirtori CR, Anderson JW, Arnoldi A: Nutritional and nutraceutical considerations for dyslipidemia. Future Lipidology 3:313-339, 2007.
65. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R: Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78:965-978, 2003.
66. Ashen MD, Blumenthal RS: Clinical practice: low HDL cholesterol levels. N Engl J Med 353:1252-1260, 2005.
67. Anderson JW, Konz EC: Obesity and disease management: effects of weight loss on comorbid conditions. Obes Res 9(suppl 4):326S-334S, 2001.
68. Ginsberg HN: Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease: a simple question with a complicated answer. Ann Intern Med 126:912-914, 1997.
69. Jenkins DJ, Kendall CW, Faulkner DA, Nguyen T, Kemp T, Marchie A, Wong JM, deSouza R, Emam A, Vidgen E, Trautwein EA, Lapsley KG, Holmes C, Josse RG, Leiter LA, Connelly PW, Singer W: Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr 83:582-591, 2006.
70. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, deSouza R, Emam A, Parker TL, Vidgen E, Trautwein EA, Lapsley KG, Josse RG, Leiter LA, Singer W, Connelly PW: Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 81:380-387, 2005.
71. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J: A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 98:633-640, 2006.
72. Weggemans RM, Trautwein EA: Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 57:940-946, 2003.
73. Jenkins DJ, Mirrahimi A, Srichaikul K, Berryman CE, Wang L, Carlton A, Abdulnour S, Sievenpiper JI, Kendall CW, Kris-Etherton PM: Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 140:2302S-2311S, 2010.